Abstract
Background The only study on chronotype and mortality suggested small increases of all-cause and cardiovascular mortality in a 6.5-year follow-up. Our aim was to constructively replicate findings from it in a longer follow-up.
Methods A questionnaire was administered to the population-based Finnish Twin Cohort in 1981 (response rate 84%, age 24–101 years). The study population included 23,854 participants who replied to the question: “Try to assess to what extent you are a morning person or an evening person”, with four response alternatives (clearly a morning person, to some extent a morning person, to some extent an evening person, and clearly an evening person). Vital status and cause of death data were provided by nationwide registers up to the end of 2018. Hazard ratios and their 95% confidence intervals for mortality were computed; there were 8728 deaths over the follow-up period. Adjustments were made for education, alcohol, smoking, body mass index, and sleep length.
Results The model adjusted for all covariates showed a 9% increase in risk of all-cause mortality for the evening-type group (1.09, 1.01–1.18), with attenuation mainly due to smoking and alcohol, as they had larger consumption than those with morningness chronotypes. We observed no increase in cardiovascular mortality by chronotype. No increase in mortality was seen among the non-smokers who were at most light drinkers.
Conclusions Our results from this 37-year follow-up study suggest that there is little or no independent contribution of chronotype to all-cause and cardiovascular mortality.
Key messages
There is little or no independent contribution of chronotype to mortality.
The increased risk of mortality associated with eveningness appears to be mainly mediated by a larger consumption of tobacco and alcohol than in those with a morningness chronotype.
It is important to be aware of the increased health risks of evening-type persons.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
the Academy of Finland (grant # 336823) and the Sigrid Juselius Foundation
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study has been approved by the ethical committee of the Department of Public Health, University of Helsinki. Informed consent was obtained from all respondents. The current record linkage to cause-of-death data was approved by Statistics Finland (permit Dnro TK-53-1608-19) and by the Research Ethics Board, Finnish Institute for Health and Welfare (THL 220/6.02.04/2021).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: JK is supported by the Academy of Finland (grant # 336823) and the Sigrid Juselius Foundation.
Conflicts of interest: None
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.